J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1571.6
(1.89%)
INR 1571.6
(1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.02 Billion INR | 16.73% |
| 2022 | 4.3 Billion INR | 5.01% |
| 2021 | 4.09 Billion INR | 17.99% |
| 2020 | 3.47 Billion INR | 26.5% |
| 2019 | 2.74 Billion INR | 12.68% |
| 2018 | 2.43 Billion INR | 14.05% |
| 2017 | 2.13 Billion INR | 6.78% |
| 2016 | 2 Billion INR | 6.48% |
| 2015 | 1.87 Billion INR | 25.09% |
| 2014 | 1.5 Billion INR | 11.81% |
| 2013 | 1.34 Billion INR | 28.57% |
| 2012 | 1.04 Billion INR | 3.47% |
| 2011 | 1.01 Billion INR | -9.53% |
| 2010 | 1.11 Billion INR | 33.78% |
| 2009 | 834.71 Million INR | 3.34% |
| 2008 | 807.74 Million INR | 8.14% |
| 2007 | 746.91 Million INR | -10.63% |
| 2006 | 835.72 Million INR | 29.96% |
| 2005 | 643.06 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 5.02 Billion INR | 16.73% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 4.24 Billion INR | 0.0% |
| 2023 Q4 | 5.02 Billion INR | 0.0% |
| 2022 Q4 | 4.3 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 4.44 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 4.3 Billion INR | 5.01% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 4.09 Billion INR | 17.99% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 4.09 Billion INR | 0.0% |
| 2021 Q2 | 3.63 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 3.77 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 3.47 Billion INR | 26.5% |
| 2020 Q4 | 3.47 Billion INR | 0.0% |
| 2019 Q4 | 2.74 Billion INR | 0.0% |
| 2019 Q2 | 2.42 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 2.74 Billion INR | 12.68% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 2.43 Billion INR | 14.05% |
| 2018 Q4 | 2.43 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 2.13 Billion INR | 6.78% |
| 2016 Q4 | 2 Billion INR | 0.0% |
| 2016 FY | 2 Billion INR | 6.48% |
| 2015 FY | 1.87 Billion INR | 25.09% |
| 2015 Q4 | 1.87 Billion INR | 0.0% |
| 2014 FY | 1.5 Billion INR | 11.81% |
| 2013 FY | 1.34 Billion INR | 28.57% |
| 2012 FY | 1.04 Billion INR | 3.47% |
| 2011 FY | 1.01 Billion INR | -9.53% |
| 2010 FY | 1.11 Billion INR | 33.78% |
| 2009 FY | 834.71 Million INR | 3.34% |
| 2008 FY | 807.74 Million INR | 8.14% |
| 2007 FY | 746.91 Million INR | -10.63% |
| 2006 FY | 835.72 Million INR | 29.96% |
| 2005 FY | 643.06 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 69.425% |
| Hester Biosciences Limited | 755.81 Million INR | -564.863% |
| Aarti Drugs Limited | 4.85 Billion INR | -3.421% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 21.832% |
| Albert David Limited | 436.12 Million INR | -1052.226% |
| Alembic Limited | 113.4 Million INR | -4331.305% |
| Alkem Laboratories Limited | 26.61 Billion INR | 81.117% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -1595.275% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -248.873% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -19608.593% |
| Brooks Laboratories Limited | 96.1 Million INR | -5128.597% |
| Eris Lifesciences Limited | 1.89 Billion INR | -165.833% |
| FDC Limited | 3.88 Billion INR | -29.217% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 24.615% |
| Gufic Biosciences Limited | 2 Billion INR | -150.651% |
| Hikal Limited | 3.03 Billion INR | -65.452% |
| Ind-Swift Limited | 640.91 Million INR | -684.051% |
| Innova Captab Limited | 1.44 Billion INR | -248.927% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -18.282% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -3250.737% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 61.034% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -551.189% |
| Lupin Limited | 49.53 Billion INR | 89.856% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -306.431% |
| Medico Remedies Limited | 163.37 Million INR | -2975.864% |
| Morepen Laboratories Limited | 2.48 Billion INR | -102.141% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 29.139% |
| Orchid Pharma Limited | 2.64 Billion INR | -90.182% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -360.554% |
| RPG Life Sciences Limited | 1.01 Billion INR | -397.535% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -12500.552% |
| Sigachi Industries Limited | 707.2 Million INR | -610.556% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -39.703% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -117.353% |
| Themis Medicare Limited | 705.74 Million INR | -612.03% |
| Unichem Laboratories Limited | 7.04 Billion INR | 28.689% |
| Vaishali Pharma Limited | 3.79 Million INR | -132243.956% |
| Wanbury Limited | 360.23 Million INR | -1294.962% |
| Windlas Biotech Limited | 621.89 Million INR | -708.037% |
| ZIM Laboratories Limited | 812.62 Million INR | -518.376% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -4705.167% |
| Ipca Laboratories Limited | 24.71 Billion INR | 79.666% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 94.908% |
| Venus Remedies Limited | 1.21 Billion INR | -312.943% |
| Sakar Healthcare Limited | 277.32 Million INR | -1712.003% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 94.877% |
| Divi's Laboratories Limited | 31.84 Billion INR | 84.218% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -120.513% |
| Mankind Pharma Limited | 15.53 Billion INR | 67.652% |
| Sequent Scientific Limited | 3.46 Billion INR | -45.137% |
| Laurus Labs Limited | 18.45 Billion INR | 72.77% |
| Neuland Laboratories Limited | 3.5 Billion INR | -43.401% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 80.004% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 85.4% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -1638.506% |
| Wockhardt Limited | 6.4 Billion INR | 21.483% |
| Bal Pharma Limited | 878.11 Million INR | -472.261% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 92.093% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -324.248% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -11930.405% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -38.417% |
| Shilpa Medicare Limited | 3.44 Billion INR | -45.685% |
| Valiant Laboratories Limited | 100.15 Million INR | -4917.373% |
| Ajanta Pharma Limited | 8.28 Billion INR | 39.337% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -1349.169% |
| Granules India Limited | 13 Billion INR | 61.362% |
| Medicamen Biotech Limited | 593.75 Million INR | -746.33% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -2283.654% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 77.95% |
| NATCO Pharma Limited | 7 Billion INR | 28.264% |
| Suven Life Sciences Limited | 7.08 Million INR | -70825.9% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -5029.537% |
| Strides Pharma Science Limited | 11.26 Billion INR | 55.382% |
| Indoco Remedies Limited | 3.53 Billion INR | -42.33% |
| Alpa Laboratories Limited | 136.65 Million INR | -3577.27% |
| Lasa Supergenerics Limited | 190.43 Million INR | -2538.762% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -33871.741% |